生命科学资讯

Med-tech gainers and losers for Jan. 5-9, 2026

FDA lifts partial hold on Merck, Daiichi's Phase 3 lung cancer study

Walmart makes tepid return to healthcare

My latest favorite anti-aging device is 20% off on Amazon - New York Post

Financings for Jan. 12, 2026

In the clinic for Jan. 12, 2026

Other news to note for Jan. 12, 2026

Regulatory actions for Jan. 12, 2026

Illumina names former NIH genomics director as chief medical officer - MedTech Dive

AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations

Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report

Boston Scientific snaps up Valencia Technologies to bolster urology offerings

Haemonetics to shell out up to €185M to acquire device maker Vivasure

Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment

Bayer boosts imaging portfolio with Attralus deal for 2 diagnostic tracers

AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGen

Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratory

JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

Biggest gainers and losers for Jan. 5-9, 2026

TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory - PR Newswire